Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-05-16Clinical Trial Update: Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 1]
Clinical trial update for a Phase 1 study of Cytolytic Viral Activation Therapy (CVAT) in recurrent/metastatic nasopharyngeal carcinoma; the…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Vestibular Function After Chemoradiotherapy for Nasopharyngeal Carcinoma
This entry provides an update on a clinical trial examining vestibular function after chemoradiotherapy for nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT [Phase 2]
An ongoing Phase 2 trial evaluating FORRAD for radiation-induced mucositis in patients with nasopharyngeal carcinoma undergoing IMRT; no eff…
-
CLINICAL_TRIALS research · 2016-04-06Clinical Trial Update: Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT [Phase 2]
Phase 2 clinical trial comparing FORRAD with Biafine (trolamine) for management of radiation dermatitis in patients with nasopharyngeal carc…
-
CLINICAL_TRIALS research · 2016-02-19Clinical Trial Update: Polymorphisms in Key Genes of Glycolytic Pathway: Influence on Radiosensitivity in Nasopharyngeal Carcinoma
This clinical trial update investigates whether polymorphisms in key glycolytic pathway genes affect radiosensitivity in Nasopharyngeal Carc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating whether adding bevacizumab to paclitaxel/carboplatin improves efficacy and safety in metastatic nasopharyngeal carc…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer [Phase 2]
Phase 2 trial evaluating pazopanib hydrochloride for stage IV or recurrent nasopharyngeal carcinoma has completed. Results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial compares cisplatin plus docetaxel with cetuximab plus cisplatin and docetaxel in metastatic nasopharyngeal carcinoma; the st…
-
CLINICAL_TRIALS research · 2015-12-09Clinical Trial Update: Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy [NA]
A clinical trial update examining pharmacokinetic-guided dosing of docetaxel and paclitaxel in non-small cell lung cancer, nasopharyngeal ca…
-
CLINICAL_TRIALS research · 2015-12-04Clinical Trial Update: Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 clinical trial is evaluating a triple chemotherapy regimen (induction, concurrent, and adjuvant) for high-risk nasopharyngeal carc…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma [Phase 3]
Phase 3 clinical trial evaluating intensity-modulated radiotherapy with or without concurrent chemotherapy for stage II nasopharyngeal carci…
-
CLINICAL_TRIALS research · 2015-11-13Clinical Trial Update: Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma Patients
This clinical trial update reports on a retrospective analysis examining how prognosis affects outcomes in patients with nasopharyngeal carc…
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma [Phase 2]
This update reports the completion of a Phase 2 study evaluating chemotherapy in combination with Nimotuzumab for untreated metastatic nasop…
-
CLINICAL_TRIALS research · 2015-09-02Clinical Trial Update: The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial investigating whether a COX-2 inhibitor can increase radiosensitivity in nasopharyngeal carcinoma; status is currently unknown…
-
CLINICAL_TRIALS other · 2015-08-19Clinical Trial Update: Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma [Phase 4]
This entry reports a Phase IV clinical trial of Nimotuzumab for nasopharyngeal carcinoma. The current trial status is listed as UNKNOWN.
-
CLINICAL_TRIALS research · 2015-08-03Clinical Trial Update: Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli
A completed retrospective clinical study at C. S. Parc Tauli examining nasopharyngeal carcinoma.
-
CLINICAL_TRIALS research · 2015-07-17Clinical Trial Update: Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma [Phase 3]
This Phase 3 trial compares different neoadjuvant chemotherapy regimens in patients with advanced nasopharyngeal carcinoma, assessing acute …
-
CLINICAL_TRIALS trial_result · 2015-07-10Clinical Trial Update: Administration of Epstein Barr Virus - Specific Cytotoxic T-Lymphocytes to Metastatic EBV-Positive Nasopharygneal Cancer [Phase 1]
Phase 1 clinical trial evaluating administration of Epstein-Barr virus-specific cytotoxic T-lymphocytes to patients with metastatic EBV-posi…
-
CLINICAL_TRIALS trial_result · 2015-06-19Clinical Trial Update: OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy [Phase 1]
Phase 1 trial evaluating OPB-51602 in locally advanced nasopharyngeal carcinoma before definitive chemoradiotherapy; the study was terminate…
-
CLINICAL_TRIALS withdrawal · 2015-06-15Clinical Trial Update: NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation [Phase 2]
A Phase 2 trial evaluating adjuvant chemotherapy versus observation after concurrent chemoradiation for nasopharyngeal carcinoma has been te…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
A completed clinical trial evaluating longitudinal plasma EBV DNA in nasopharyngeal carcinoma across endemic and non-endemic populations.
-
CLINICAL_TRIALS withdrawal · 2015-05-27Clinical Trial Update: S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx [Phase 2]
A Phase 2 clinical trial (S9715) evaluating chemotherapy and radiation therapy for advanced nasopharyngeal carcinoma was withdrawn.
-
CLINICAL_TRIALS research · 2015-04-03Clinical Trial Update: Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis
A clinical trial from National Taiwan University Hospital investigates the role of mucins and mucin glycosylating enzymes in nasopharyngeal …
-
CLINICAL_TRIALS trial_result · 2015-02-25Clinical Trial Update: A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma [Phase 3]
This entry reports the results of a Phase 3 multicenter trial comparing induction C/T followed by concurrent chemoradiotherapy versus concur…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 clinical trial tests endostatin in combination with chemotherapy for metastatic nasopharyngeal carcinoma, sponsored by Zhejiang Ca…